Filed: 5/15/2026ACC: 0001831942-26-000025
📋 What this filing means
COMMODORE CAPITAL LP filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $1.73B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$1.73B
Total AUM (reported)
113.45M
Total Shares
Allocation by class
COM$1.05B60.9%
COM NEW$366.80M21.2%
SHS$148.51M8.6%
COM SHS$136.01M7.9%
CLASS A ORD SHS$19.34M1.1%
USD CL A ORD SHS$5.08M0.3%
Portfolio Concentration
Top 3$446.04M25.8%
4–10$614.35M35.5%
11–25$561.99M32.5%
Rest$106.07M6.1%
Top 3 weight
25.8%
Top 10 weight
61.3%
Voting Authority Distribution
Total shares with voting rights: 113.45M
Sole
Full voting authority
113.45M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
RELAY THERAPEUTICS INC
SOLEShares17M
TypeSH
Market value$169.15M
9.79%
Sole
17M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares4.20M
TypeSH
Market value$148.51M
8.59%
Sole
4.20M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares3.27M
TypeSH
Market value$128.38M
7.43%
Sole
3.27M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares2.89M
TypeSH
Market value$111.16M
6.43%
Sole
2.89M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares1.91M
TypeSH
Market value$96.46M
5.58%
Sole
1.91M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares2.48M
TypeSH
Market value$94.79M
5.48%
Sole
2.48M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares2.70M
TypeSH
Market value$85.54M
4.95%
Sole
2.70M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares833.60K
TypeSH
Market value$85.40M
4.94%
Sole
833.60K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares5.65M
TypeSH
Market value$78.53M
4.54%
Sole
5.65M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$62.47M
3.61%
Sole
750K
Shared
0.00
None
0.00
ALTO NEUROSCIENCE INC
SOLEShares2.72M
TypeSH
Market value$61.22M
3.54%
Sole
2.72M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.92M
TypeSH
Market value$54.21M
3.14%
Sole
1.92M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares3.17M
TypeSH
Market value$51.37M
2.97%
Sole
3.17M
Shared
0.00
None
0.00
DAMORA THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$50.22M
2.91%
Sole
1.94M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares825K
TypeSH
Market value$47.97M
2.78%
Sole
825K
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$37.80M
2.19%
Sole
2M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.50M
TypeSH
Market value$36.99M
2.14%
Sole
1.50M
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares2.83M
TypeSH
Market value$36.41M
2.11%
Sole
2.83M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares2.27M
TypeSH
Market value$35.26M
2.04%
Sole
2.27M
Shared
0.00
None
0.00
CORVUS PHARMACEUTICALS INC
SOLEShares2.26M
TypeSH
Market value$33.05M
1.91%
Sole
2.26M
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares1M
TypeSH
Market value$27.75M
1.61%
Sole
1M
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares6.34M
TypeSH
Market value$26.42M
1.53%
Sole
6.34M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares652.43K
TypeSH
Market value$21.84M
1.26%
Sole
652.43K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares2.58M
TypeSH
Market value$21.81M
1.26%
Sole
2.58M
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares8.70M
TypeSH
Market value$19.65M
1.14%
Sole
8.70M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RELAY THERAPEUTICS INCSOLE | COM | 17M | SH | $169.15M 9.79% | 17M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 4.20M | SH | $148.51M 8.59% | 4.20M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 3.27M | SH | $128.38M 7.43% | 3.27M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 2.89M | SH | $111.16M 6.43% | 2.89M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 1.91M | SH | $96.46M 5.58% | 1.91M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 2.48M | SH | $94.79M 5.48% | 2.48M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 2.70M | SH | $85.54M 4.95% | 2.70M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 833.60K | SH | $85.40M 4.94% | 833.60K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 5.65M | SH | $78.53M 4.54% | 5.65M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 750K | SH | $62.47M 3.61% | 750K | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 2.72M | SH | $61.22M 3.54% | 2.72M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.92M | SH | $54.21M 3.14% | 1.92M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 3.17M | SH | $51.37M 2.97% | 3.17M | 0.00 | 0.00 |
DAMORA THERAPEUTICS INCSOLE | COM NEW | 1.94M | SH | $50.22M 2.91% | 1.94M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 825K | SH | $47.97M 2.78% | 825K | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 2M | SH | $37.80M 2.19% | 2M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.50M | SH | $36.99M 2.14% | 1.50M | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 2.83M | SH | $36.41M 2.11% | 2.83M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 2.27M | SH | $35.26M 2.04% | 2.27M | 0.00 | 0.00 |
CORVUS PHARMACEUTICALS INCSOLE | COM | 2.26M | SH | $33.05M 1.91% | 2.26M | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 1M | SH | $27.75M 1.61% | 1M | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 6.34M | SH | $26.42M 1.53% | 6.34M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 652.43K | SH | $21.84M 1.26% | 652.43K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 2.58M | SH | $21.81M 1.26% | 2.58M | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 8.70M | SH | $19.65M 1.14% | 8.70M | 0.00 | 0.00 |
Page 1 of 2